Edwin O'Connor

Edwin O'Connor

Goodwin

Contact
View Bio
RSS

Latest Publications

Share:

The Impact of COVID-19 on Disclosure Obligations for Public Companies in the Life Sciences Industry

The ongoing global outbreak of the novel coronavirus (COVID-19) raises important considerations for life sciences companies subject to U.S. Securities and Exchange Commission (“SEC”) disclosure and reporting requirements. As...more

3/30/2020  /  Coronavirus/COVID-19 , Disclosure Requirements , Insider Trading , Life Sciences , Publicly-Traded Companies , Securities and Exchange Commission (SEC) , Securities Litigation
1 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide